eli lilly semaglutide direct launches single-dose Zepbound to ease self-pay access Eli Lilly strikes Zepbound deal
Description
Clinical practice recommendation on periprocedural use of GLP-1/GIP receptor agonists
Key Takeaways: For clinicians evaluating patients using GLP-1 therapy: Breath testing remains clinically useful
We believe that sustainable weight loss is not about how many pills you take, but about finding the right tools and support to help your body function at its best
Slurred speech
Although there is a concern for the development of rare pancreatitis, pancreatic cancer or thyroid cancer, a meta-analysis of several databases did not suggest any increased risk of acute pancreatitis or pancreatic cancer with GLP-1RA treatment in T2DM patients [17]
Xiang J, Ding XY, Zhang W, et al
